Kristen Harrington-Smith serves as ADC Therapeutics' Chief Commercial Officer, which she joined in November 2022, and brings more than 20 years of experience in the pharmaceutical industry. She was most recently Chief Commercial Officer at ImmunoGen, and previously held roles at Novartis including U.S. Commercial Head of Hematology, where she was responsible for the Kymriah CAR-T launch. She holds a B.A. from Williams College and an M.B.A. from the Kenan-Flagler Business School at the University of North Carolina.